Jacobs, G.A.Gerber, M.Malan, M.M.Du Preez, J.Du Plessis, J.2016-01-262016-01-262010Jacobs, G.A. et al. 2010. Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients. (In Perspectives in percutaneous penetration, 12th International Conference, 7-10 April, 2010, La Grande Motte, France). Journal of pharmacy and pharmacology, 62(6):789. [https://doi.org/10.1211/jpp.62.06.0016]0022-35732042-7158 (Online)http://hdl.handle.net/10394/16030https://onlinelibrary.wiley.com/doi/abs/10.1211/jpp.62.06.0016https://doi.org/10.1211/jpp.62.06.0016Due to their compromised immune systems, HIV/ AIDS- infected individuals are more susceptible to skin infections. Since fungal and viral cutaneous manifestations are frequently encountered in combination in HIV/AIDS patients, it is appropriate to formulate a topical product containing both ketoconazole (antifungal) and aciclovir (antiviral)enPresentation